Fungal infections: A growing threat.
作者信息
Gómez Beatriz L, Escandón Patricia
机构信息
Grupo de Estudios en Microbiología Translacional y Enfermedades Emergentes (MICROS), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, D.C., Colombia.
Grupo de Microbiología, Instituto Nacional de Salud, Bogotá, D.C., Colombia.
出版信息
Biomedica. 2023 Aug 31;43(Sp. 1):11-16. doi: 10.7705/biomedica.7214.
Abstract
摘要
相似文献
1
Fungal infections: A growing threat.
Biomedica. 2023 Aug 31;43(Sp. 1):11-16. doi: 10.7705/biomedica.7214.
2
Fungal Infections as an Uprising Threat to Human Health: Chemosensitization of Fungal Pathogens With AFP From .
Front Cell Infect Microbiol. 2022 May 25;12:887971. doi: 10.3389/fcimb.2022.887971. eCollection 2022.
3
Fungal infections: a growing threat.
Public Health Rep. 1996 May-Jun;111(3):226-35.
4
Implantation Mycoses and Invasive Fungal Infections with Cutaneous Involvement in Tropical Taiwan: An 11-Year Retrospective Study of a Medical Center.
J Fungi (Basel). 2023 Mar 5;9(3):322. doi: 10.3390/jof9030322.
6
Special Issue: Fungal Pathogenesis in Humans: The Growing Threat.
Genes (Basel). 2019 Feb 12;10(2):136. doi: 10.3390/genes10020136.
7
Emerging IL-12 family cytokines in the fight against fungal infections.
Cytokine. 2018 Nov;111:398-407. doi: 10.1016/j.cyto.2018.05.019. Epub 2018 May 21.
8
Systemic mycoses: a potential alert for complications in COVID-19 patients.
Future Microbiol. 2020 Sep;15:1405-1413. doi: 10.2217/fmb-2020-0156.
9
Surfactant Protein D Recognizes Multiple Fungal Ligands: A Key Step to Initiate and Intensify the Anti-fungal Host Defense.
Front Cell Infect Microbiol. 2020 May 29;10:229. doi: 10.3389/fcimb.2020.00229. eCollection 2020.
10
Neutrophil extracellular traps in fungal infections: A seesaw battle in hosts.
Front Immunol. 2022 Sep 14;13:977493. doi: 10.3389/fimmu.2022.977493. eCollection 2022.
本文引用的文献
1
The importance of antimicrobial resistance in medical mycology.
Nat Commun. 2022 Sep 12;13(1):5352. doi: 10.1038/s41467-022-32249-5.
2
Disaster Microbiology-a New Field of Study.
mBio. 2022 Aug 30;13(4):e0168022. doi: 10.1128/mbio.01680-22. Epub 2022 Aug 3.
3
Fungal infections: Pathogenesis, antifungals and alternate treatment approaches.
Curr Res Microb Sci. 2022 Apr 27;3:100137. doi: 10.1016/j.crmicr.2022.100137. eCollection 2022.
4
Population genomics confirms acquisition of drug-resistant Aspergillus fumigatus infection by humans from the environment.
Nat Microbiol. 2022 May;7(5):663-674. doi: 10.1038/s41564-022-01091-2. Epub 2022 Apr 25.
5
Antifungal drug resistance: an update.
Eur J Hosp Pharm. 2022 Mar;29(2):109-112. doi: 10.1136/ejhpharm-2020-002604.
6
The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin.
Drugs. 2021 Oct;81(15):1703-1729. doi: 10.1007/s40265-021-01611-0. Epub 2021 Oct 9.
7
Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave?
Lancet Respir Med. 2021 Aug;9(8):e77. doi: 10.1016/S2213-2600(21)00265-4. Epub 2021 Jun 3.
8
Drug-drug interaction database for safe prescribing of systemic antifungal agents.
Ther Adv Infect Dis. 2021 Apr 30;8:20499361211010605. doi: 10.1177/20499361211010605. eCollection 2021 Jan-Dec.
9
Climate change and the emergence of fungal pathogens.
PLoS Pathog. 2021 Apr 29;17(4):e1009503. doi: 10.1371/journal.ppat.1009503. eCollection 2021 Apr.
10
Extensive Genetic Diversity and Widespread Azole Resistance in Greenhouse Populations of Aspergillus fumigatus in Yunnan, China.
mSphere. 2021 Feb 10;6(1):e00066-21. doi: 10.1128/mSphere.00066-21.
Zotero 插件